Drugs / Inactivated Poliomyelitis Vaccine (IPV)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04232943 | Jan 2020 → Feb 2021 | poliomyelitis | PATH | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Poliomyelitis Vaccine (IPV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04232943 ↗ |
| Modality | Vaccine | “IMOVAX® Polio is a highly purified, inactivated poliovirus vaccine.” NCT04232943 ↗ |